Rare diseases
Investigational molecules
Locations
Study on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients
SpainStudy of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes
SpainStudy of Berubicin versus lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure
SpainStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
SpainStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
SpainStudy on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)
SpainStudy on Amivantamab, Lazertinib, and Bevacizumab for Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer After Treatment Progression
SpainStudy of Zanidatamab and Tislelizumab Combined with Chemotherapy for Patients with Advanced or Metastatic HER2-positive Gastroesophageal Cancer
SpainTitle: Comparing Brentuximab Vedotin plus ESHAP versus ESHAP alone in treating patients with relapsed or refractory classical Hodgkin's Lymphoma
SpainA Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer
SpainStudy on the Safety and Effectiveness of ABTL0812 with Drug Combination for Patients with Metastatic Pancreatic Cancer
SpainStudy of Rituximab, Gemcitabine, Dexamethasone, and Platinum with or without Selinexor for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
